期刊
INFLAMMATORY BOWEL DISEASES
卷 16, 期 9, 页码 1514-1525出版社
OXFORD UNIV PRESS INC
DOI: 10.1002/ibd.21262
关键词
Bifidobacterium lactis; colitis; colitis-associated colon cancer; nuclear factor kappa B; inflammatory bowel disease
资金
- Yonsei University College of Medicine [6-20070224]
Background: The aim of this study was to investigate the antiinflammatory effects of Bifidobacterium lactis on intestinal epithelial cells (IECs) and on experimental acute murine colitis and its tumor prevention effects on colitis-associated cancer (CAC) in mice. Methods: Human HT-29 cells were stimulated with IL-1 beta, lipopolysaccharides, or tumor necrosis factor-alpha with and without B. lactis, and the effects of B. locus on nuclear factor kappa B (NF-kappa B) signaling in IEC were examined. For in vivo study, dextran sulfate sodium (DSS)-treated mice were fed with and without B. lactis. Finally, we induced colonic tumors in mice by azoxymethane (AOM) and DSS and evaluated the effects of B. lactis on tumor growth. Results: B. lactis significantly suppressed NF-kappa B activation, including NF-kappa B-binding activity and NF-kappa B-dependent reporter gene expression in a dose-dependent manner, and suppressed I kappa B-alpha degradation, which correlated with the downregulation of NF-kappa B-dependent gene products. Moreover. B. locals suppressed the development of acute colitis in mice. Compared with the DSS group, the severity of DSS-induced colitis as assessed by disease activity index, colon length, and histological score was reduced in the B. lactis-treated group. In the CAC model, the mean number and size of tumors in the B. lactis-treated group were significantly lower than those in the AOM group. Conclusions: Our data demonstrate that B. lactis inhibits NF-kappa B and NF-kappa B-regulated genes in IEC and prevents acute colitis and CAC in mice. These results suggest that B. lactis could be a potential preventive agent for CAC as well as a therapeutic agent for inflammatory bowel disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据